The expanding pipeline of small molecule medications, their rising intricacy, and the requirement for specialized knowledge are fueling the demand for pharmaceutical contract manufacturing in the fill-finish sector. Moreover, with a greater focus...
The global increase in investment, consequently fueling a significant recovery in developed markets, is observed as a vital market driver for the pharmaceutical-grade synthetic camphor market. Nonetheless, the change in positive market sentiments...
The increasing preference for biologics and biosimilars is fueling the demand for the sterile injectable contract manufacturing sector. The market size for sterile injectable contract manufacturing was worth USD 15.96 billion in 2024 and is...
India has played a significant role in supplying cost-effective generic drugs, supporting healthcare systems worldwide for a considerable amount of time. Yet, worries have arisen about the provision of healthcare in countries relying on these...
India's status as the "pharmacy of the world" is based on its ability to create drug details and nonexclusive medications. Be that as it may, this standing lays on a tricky establishment, with roughly 70% of its Dynamic Drug Fixings (APIs) obtained..
Long-term health management products, specifically chronic therapies, have been driving the growth of the Indian Pharmaceutical Market (IPM) with a 10% increase, in contrast to acute therapies which saw a 2% growth, showing a trend towards prolong...
Glenmark became the first Indian company to introduce a biosimilar of the anti-diabetic GLP-1 drug Liraglutide in India. Additionally, it has revealed a number of collaborations to introduce new drugs, such as partnerships with Jiangsu Alphamab...
The United States continues to be a crucial market for the Indian pharmaceutical industry, representing approximately 30% of overall sales and capturing a 40% share of the market in terms of volume. Despite possible risks from changes in duty...
Strengthening of Pharmaceutical Industry (SPI)' initiative, backed by Rs 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality and sustainability across pharma clusters and MSMEs nationwide....
The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the...
.jpg)
.jpg)
, CDSCO.jpg)